EUVIMEDEUVIMED entdecken
Crossref

Late-onset clozapine-induced neutropenia treated with lithium

Pelin Tas Durmus

Dusunen Adam: The Journal of Psychiatry and Neurological Sciences · 2019

DOI: 10.14744/dajpns.2019.00011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dusunen Adam: The Journal of Psychiatry and Neurological Sciences, 2019. Verfasst von Pelin Tas Durmus. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clozapine is a second-generation antipsychotic drug, proven to be effective in treatment-resistant schizophrenia.Among patients using clozapine; the incidence of neutropenia is approximately 3% and the incidence of agranulocytosis is approximately 1%.This side effect is diminishing after 18 weeks of drug initiation.Here, we present a case of clozapine-induced neutropenia in a schizophrenic patient seen after 7 years of clozapine use and its treatment with lithium supplementation.

Zitieren

APA

Durmus, P. T. (2019). Late-onset clozapine-induced neutropenia treated with lithium. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.14744/dajpns.2019.00011

Vancouver

Durmus PT. Late-onset clozapine-induced neutropenia treated with lithium. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. 2019. doi:10.14744/dajpns.2019.00011

BibTeX
@article{Durmus2019,
  author = {Durmus, Pelin Tas},
  title = {Late-onset clozapine-induced neutropenia treated with lithium},
  journal = {Dusunen Adam: The Journal of Psychiatry and Neurological Sciences},
  year = {2019},
  doi = {10.14744/dajpns.2019.00011}
}
Kostenlos starten →